Latest news for Fiore Cannabis (OTC:FIORF) Stock

Fiore Cannabis Ltd is engaged in the production and cultivation of medicinal and recreational cannabis. Also, the company is engaged in the business of hemp-seed oil and skin products. Its brands are Fiore, Purecloud9, Diamantelabs, Surfer, and The Weekender. The company's geographical segments are Canada and United States.

Cannabis

Penny Stocks

Small Cap

Markets

AAWH

AYRWF

BMMJ

FFNTF

FIORF

HBORF

JUSHI HLDGS INC CL B by Jushi Holdings Inc.

JUSHF

LOWLF

PLNHF

TLLTF

UNRIVALED BRANDS INC by Unrivaled Brands, Inc.

UNRV

July 6, 2022: Last week, California’s onerous cultivation tax ($161/lb.) was officially eliminated. While far from solving all the issues for California operators, the tax change meaningfully reduces the break-even threshold for growers and particularly those with the biggest scale in capacity.

CA Cultivation Tax Elimination, Meaningfully Eases Pricing Pressures And Likely Drives Consolidation

News

Financing

Management

Success Stories

Startups

Small Business

CSE:FIOR

Fiore Cannabis Ltd. (CSE: FIOR) (OTCQB: FIORF) a company that intends to become a vertically integrated Canadian-American multi-state operator announced the closing of its Colorado merger with Unified Global on May 13, 2022. 

Fiore Cannabis: M&amp;A In Colorado, Non-Binding Term Sheet For Financing Up To C$30M With Institutional Fund

Earnings

A multi-state cannabis company Fiore Cannabis Ltd. (CSE: FIOR) (OTCQB: FIORF) released its third-quarter 2021 financial results Monday with revenues of $1.11 million, up by 101% from $550,000 in the same quarter of 2020.

Fiore Cannabis Reports First Quarterly Net Profit, Focuses On U.S. Possible Federal Legalization

FIORE CANNABAIS LTD by Fiore Cannabis Ltd.

Fiore Cannabis Ltd

Successful traders know how to recognize which price levels in a certain market are important. These are called support and resistance levels. When a stock reaches one of them there is a good chance it reverses. Traders can profit from these reversals.
Successful traders also understand the concept of market memory. This refers to how a price level can be important for a long time. It could be weeks, months, or even years. 
United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) has a good memory. That's why our technical analysis experts have made it our Stock of the Day.
As you can see on the chart, the $156.00 level was first support in September 2020. Then it was support in March 2021. It was also support once again in October 2022. Market memory kept this support intact for more than two years.
An important dynamic of technical analysis is understanding how a price level that had once been resistance can convert into a support level. This can also be seen on the chart. $176.50 was resistance for <a href="https://www.benzinga.com/quote/UPS">UPS</a> in October 2020 and April 2021. Then it became a support level in October 2021.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23121813/1-22-1024x547.png" alt=" United Parcel Service, Inc." class="wp-image-451893" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23121813/1-22-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23121813/1-22-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23121813/1-22-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23121813/1-22.png 1044w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Also Read: <a href="https://www.benzinga.com/news/earnings/24/07/39903596/ups-q2-earnings-revenue-and-eps-miss-annual-outlook-cut-restarts-stock-buyback">UPS Q2 Earnings: Revenue And EPS Miss, Annual Outlook Cut, Restarts Stock Buyback</a>
Resistance can convert into support when remorseful sellers try to buy their shares back. Some traders and investors who sold around $176.50 were happy when the price headed lower soon after. But when the stock reversed and moved to higher prices, many of them regretted their decision to sell.
Some of these remorseful sellers decide that if they can buy their shares back at the same prices sold, they will do so. So, <a href="https://www.benzinga.com/news/earnings/24/07/39903596/ups-q2-earnings-revenue-and-eps-miss-annual-outlook-cut-restarts-stock-buyback">UPS</a> dropped back to $176.50 in October 2021, they placed buy orders and this large concentration of orders resulted in support forming at the price that had been resistance.
A similar thing may be about to happen now.
After a weak earnings report, the shares dropped to around $124.00. This level was resistance in August 2018, November 2019 and August 2020.
If UPS has a really good market memory, it will find support around $124.00. This may be a good time to buy it.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39910693/tesla-analyst-asks-do-earnings-matter-ahead-of-q2-report-robotaxis-china-ev-guidanc">Tesla Analyst Asks &#8216;Do Earnings Matter?&#8217; Ahead Of Q2 Report: Robotaxis, China, EV Guidance In Focus</a>
Photo: Shutterstock

Technicals

Trading Ideas

Stock of the Day: UPS Has A Good Memory

Arista Networks's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) short percent of float has fallen 23.97% since its last report. The company recently reported that it has 3.36 million shares sold short, which is 1.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.2 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Arista Networks Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721755821_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Arista Networks has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Arista Networks's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Arista Networks's peer group average for short interest as a percentage of float is 9.16%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

ANET

Looking Into Arista Networks's Recent Short Interest

Pool (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>) has outperformed the market over the past 10 years by 9.01% on an annualized basis producing an average annual return of 19.92%. Currently, Pool has a market capitalization of $12.71 billion. 
Buying $1000 In POOL: If an investor had bought $1000 of POOL stock 10 years ago, it would be worth $6,066.18 today based on a price of $331.57 for POOL at the time of writing.
<h3>Pool's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721755819_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

POOL

Here's How Much You Would Have Made Owning Pool Stock In The Last 10 Years

Bancorp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NYSE">TBBK</a>) short percent of float has risen 4.16% since its last report. The company recently reported that it has 6.40 million shares sold short, which is 15.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Bancorp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721755817_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bancorp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Bancorp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Bancorp's peer group average for short interest as a percentage of float is 4.45%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TBBK

How Is The Market Feeling About Bancorp?

Morgan Stanley analyst Tejas Savant maintains IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Overweight and raises the price target from $270 to $280.

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on IQVIA Hldgs, Raises Price Target to $280

Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) has outperformed the market over the past 5 years by 33.21% on an annualized basis producing an average annual return of 46.18%. Currently, Viking Therapeutics has a market capitalization of $5.73 billion. 
Buying $1000 In VKTX: If an investor had bought $1000 of VKTX stock 5 years ago, it would be worth $6,649.17 today based on a price of $51.93 for VKTX at the time of writing.
<h3>Viking Therapeutics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721755814_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VKTX

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,600 Today

We live in a country that values freedom and independence above all else. You have the right to worship how you want, live how you want, and educate your children how you choose. But while valuing the lack of government infringement in our personal lives, many Americans forget that financial freedom isn&#8217;t a given.
Don't Miss:
<ul>
<li>Rory McIlroy&#8217;s mansion in Florida is worth $22 million today, doubling from 2017 —<a href="https://benzinga.com/money/rory-mcilroys-florida-mansion-doubled-in-value"> here&#8217;s how to get started investing in real estate with just $100</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
</ul>
In fact, with fewer social nets to keep you from falling into a financial abyss than in all of Europe, we have to work for and build our financial freedom. In a blog from the 4th of July, Suze Orman pointed out, &#8220;Financial independence is not something we snap our fingers and have to materialize right then and there. It results from a process that we create and then commit to seeing through. And that process can start at any time. Like today.&#8221;
What is financial independence to you? Is it having a stable job and an emergency fund? Is it paying off all debt? Or is it a work-optional lifestyle?&nbsp;
 Financial independence may seem far-fetched when so many Americans struggle with debt or to keep up with savings goals. Instead of snapping your fingers or wishing for the best, Orman advises changing your perspective.
 Sure, you can keep the big goals in your mind, but start with a small goal you can work toward right now. This vital move could help you hit your first financial target early this summer.&nbsp;
See Also: <a href="https://www.benzinga.com/money/realbricks">Will the surge continue or decline on real estate prices? People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a>
Orman suggests, &#8220;Make it a shortlist. No more than two or three goals. And honestly, focusing on getting rolling on one goal is great. It's up to you.&#8221; When you tackle the right goal, you&#8217;ll get relief and satisfaction that can help drive you toward the next goal.&nbsp;
The <a href="https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html#v2023">average American debt per U.S. adult</a> is $66,772, and 77% of American households have at least some type of debt. If you&#8217;re struggling with a credit card, student, or other debt, it&#8217;s time to reassess your lifestyle and see what more you can pay off.&nbsp;
 For example, if you have a 30-year $400,000 mortgage on a home you bought five years ago, paying the principal an extra $500 a month could help you pay it off eight years earlier. With a 7% interest rate, you&#8217;d save over $150,000 in interest payments. Even if you locked in a 4% interest rate, you could save over $70,000 on interest with the same repayment strategy.&nbsp;
Regardless of your views, this July and running into the election season, remember your freedom in America, including the freedom to build your financial independence. <a href="https://www.benzinga.com/money/how-to-save-money-during-inflation">Even in the face of soaring inflation</a> and interest rates, you can try <a href="https://www.benzinga.com/money/money-saving-challenge">savings challenges</a>, <a href="https://www.benzinga.com/money/budgeting-tips-for-young-adults">create a budget</a>, and define your goals. Every little bit is one more step toward your long-term independence. Remember to celebrate your success!
Read Next:
<ul>
<li>Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —<a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"> How much is that worth today?</a></li>
<li>Many are surprised by Mark Cuban&#8217;s advice for lotto winners:<a href="https://www.benzinga.com/money/mark-cubans-annuity-adv"> Cash or annuity?</a></li>
</ul>

Personal Finance

Financial Freedom Or Bust: Why Suze Orman Says Your Wallet Matters More Than Your Flag

Monster Beverage's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NYSE">MNST</a>) short percent of float has fallen 29.44% since its last report. The company recently reported that it has 22.83 million shares sold short, which is 3.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.55 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Monster Beverage Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721755811_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Monster Beverage has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Monster Beverage's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Monster Beverage's peer group average for short interest as a percentage of float is 7.18%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MNST

(MNST) - Analyzing Monster Beverage's Short Interest

Morgan Stanley analyst Ken Zerbe maintains Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Underweight and raises the price target from $39 to $42.

ZION

Morgan Stanley Maintains Underweight on Zions Bancorp, Raises Price Target to $42

Morgan Stanley analyst Betsy Graseck maintains Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a Equal-Weight and raises the price target from $44 to $46.

Morgan Stanley Maintains Equal-Weight on Truist Finl, Raises Price Target to $46

Eni S.p.A.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/E#NYSE">E</a>) disclosed securing a temporary exclusivity agreement with KKR &amp; Co. Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) to advance due diligence and finalize documents for selling a 20% to 25% stake in Enilive, based on a valuation&nbsp;between €11.5 billion and €12.5 <a target="_blank" href="https://www.eni.com/en-IT/media/press-release/2024/07/eni-enilive.html" rel="noreferrer noopener">billion</a>.
This move supports Eni&#8217;s satellite model strategy, attracting valuable new partners and funding growth at favorable multiples, confirming the value of these new ventures.
The high interest from major institutional investors may result in the sale of an additional 10% stake in Enilive.
While the final deal depends on agreeing to definitive terms, both parties are committed to negotiating.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39525949/eni-sells-alaskan-upstream-assets-to-hilcorp-in-strategic-streamlining-details" rel="noreferrer noopener">Eni Sells Alaskan Upstream Assets To Hilcorp In Strategic Streamlining: Details</a>
Biraj Borkhataria, head of Global Energy Transition Research at Royal Bank of Canada, said, &#8220;The valuation in the range of 11.5-12.5 billion euros is well above market expectations, which we think were in the range of 7-10 billion euros,&#8221; reported Reuters.
As per the report, Enilive, which specializes in biorefining, biomethane production, and smart mobility, operates over 5,000 multi-fuel stations across Europe. It aims to double its biorefining capacity to over 3 million tons by 2026.
Recently, Eni extended its long-term agreement with Vår Energi&nbsp;ASA. Under the agreement, Vår Energi will supply Eni with up to five billion cubic meters (bcm) of <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39574851/european-energy-giant-eni-seals-extended-gas-deal-with-v-r-energi-details" rel="noreferrer noopener">gas between 2024 and 2036</a>.
Investors can gain exposure to Eni via&nbsp;The Advisors? Inner Circle Fund Cambiar Aggressive Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAMX#NYSE">CAMX</a>).
Price Action: E shares are down 0.39% at $30.43, while KKR shares are up 0.56% at $118.54 at the last check Tuesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/05/38784290/eni-monetizes-oil-past-to-finance-clean-energy-future-report" target="_blank" rel="noreferrer noopener">Eni Monetizes Oil Past to Finance Clean Energy Future: Report</a></li>
</ul>

Equities

Large Cap

Asset Sales

Media

CAMX

Italy's Eni Nears Deal To Sell Enilive Stake To KKR: Details

Morgan Stanley analyst Michael Cyprys maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Overweight and raises the price target from $144 to $164.

Morgan Stanley Maintains Overweight on Blackstone, Raises Price Target to $164

Momentum investors typically don&#39;t time the market or &quot;buy low and sell high.&quot; In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that &quot;buying high and selling higher&quot; is the way to make far more money in lesser time.
Who doesn&#39;t like betting on fast-moving trending stocks? But determining the right entry point isn&#39;t easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, investors find themselves loaded up on expensive shares with limited to no upside or even a downside. So, going all-in on momentum could be risky at times.
A safer approach could be investing in bargain stocks with recent price momentum. While the Zacks Momentum Style Score (part of the Zacks Style Scores system) helps identify great momentum stocks by paying close attention to trends in a stock&#39;s price or earnings, our &#39;Fast-Paced Momentum at a Bargain&#39; screen comes handy in spotting fast-moving stocks that are still attractively priced.
There are several stocks that currently pass through the screen and Energy Transfer LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/et#NYSE">ET</a>) is one of them. Here are the key reasons why this stock is a great candidate.
A dash of recent price momentum reflects growing interest of investors in a stock. With a four-week price change of 3%, the stock of this energy-related services provider is certainly well-positioned in this regard.
While any stock can see a spike in price for a short period, it takes a real momentum player to deliver positive returns for a longer time frame. ET meets this criterion too, as the stock gained 2.5% over the past 12 weeks.
Moreover, the momentum for ET is fast paced, as the stock currently has a beta of 1.66. This indicates that the stock moves 66% higher than the market in either direction.
Given this price performance, it is no surprise that ET has a Momentum Score of A, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success.
In addition to a favorable Momentum Score, an upward trend in earnings estimate revisions has helped ET earn a Zacks Rank #2 (Buy). Our research shows that the momentum-effect is quite strong among Zacks Rank #1 and #2 stocks. That&#39;s because as covering analysts raise their earnings estimates for a stock, more and more investors take an interest in it, helping its price race to keep up.
Most importantly, despite possessing fast-paced momentum features, ET is trading at a reasonable valuation. In terms of Price-to-Sales ratio, which is considered as one of the best valuation metrics, the stock looks quite cheap now. ET is currently trading at 0.68 times its sales. In other words, investors need to pay only 68 cents for each dollar of sales.
So, ET appears to have plenty of room to run, and that too at a fast pace.
<a href="https://www.zacks.com/stock/news/2306678/energy-transfer-lp-et-shows-fast-paced-momentum-but-is-still-a-bargain-stock?cid=CS-BENZ-FT-tale_of_the_tape|fast_paced_momentum_at_a_bargain-2306678">To read this article on Zacks.com click here.</a>

Energy Transfer LP Shows Fast-Paced Momentum But Is Still a Bargain Stock

Transcode Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares are trading lower by 62% to $0.30 during Tuesday&#8217;s session after the company announced pricing of its <a href="https://www.benzinga.com/pressreleases/24/07/g39897607/transcode-therapeutics-inc-announces-pricing-of-public-offering">public offering</a>.
The public offering of 10 million shares of its common stock will be at $0.30 per share, aiming to raise $3 million before deducting expenses. The offering is set to close on July 24, pending usual conditions. 
The funds will be used for product development, including clinical trials for TTX-MC138, their lead therapeutic candidate, and related studies as well as for general corporate purposes.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39905739/veteran-wall-street-investor-downplays-recession-odds-current-bull-market-has-more-">Veteran Wall Street Investor Downplays Recession Odds: &#8216;Current Bull Market Has More Support From Earnings&#8217;</a>
<h2 class="wp-block-heading">Should I Sell My RNAZ Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
RNAZ has a 52-week high of $128.00 and a 52-week low of $0.30.

RNAZ

Why Transcode Therapeutics (RNAZ) Stock Is Down 60%

<a href="https://truthsocial.com/@realDonaldTrump/posts/112836962476504865" title="https://truthsocial.com/@realDonaldTrump/posts/112836962476504865">https://truthsocial.com/@realDonaldTrump/posts/112836962476504865</a>

Politics

General

ISRA

Trump Post On Truth Social, "Looking forward to welcoming Bibi Netanyahu at Mar-a-Lago in Palm Beach, Florida, tomorrow..."

Morgan Stanley analyst Brian Nowak maintains Shutterstock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSTK#NYSE">SSTK</a>) with a Equal-Weight and raises the price target from $55 to $58.

SSTK

Morgan Stanley Maintains Equal-Weight on Shutterstock, Raises Price Target to $58

Morgan Stanley analyst Brian Nowak maintains Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) with a Equal-Weight and raises the price target from $43 to $45.

CART

Morgan Stanley Maintains Equal-Weight on Maplebear, Raises Price Target to $45

<a href="https://asia.nikkei.com/Business/Technology/Artificial-intelligence/Lenovo-to-put-AI-into-all-PCs-by-2027-device-chief" title="https://asia.nikkei.com/Business/Technology/Artificial-intelligence/Lenovo-to-put-AI-into-all-PCs-by-2027-device-chief">https://asia.nikkei.com/Business/Technology/Artificial-intelligence/Lenovo-to-put-AI-into-all-PCs-by-2027-device-chief</a>

LNVGF

'Lenovo to put AI into all PCs by 2027: device chief' - Nikkei

While &quot;the trend is your friend&quot; when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn&#39;t easy.
The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive.
Investors looking to make a profit from stocks that are currently on the move may find our &quot;Recent Price Strength&quot; screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.
Recruit Holdings Co., Ltd. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/rcrrf#OTC">RCRRF</a>) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for &quot;trend&quot; investors.
A solid price increase over a period of 12 weeks reflects investors&#39; continued willingness to pay more for the potential upside in a stock. RCRRF is quite a good fit in this regard, gaining 32.6% over this period.
However, it&#39;s not enough to look at the price change for around three months, as it doesn&#39;t reflect any trend reversal that might have happened in a shorter time frame. It&#39;s important for a potential winner to maintain the price trend. A price increase of 9% over the past four weeks ensures that the trend is still in place for the stock of this company.
Moreover, RCRRF is currently trading at 81% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.
Looking at the fundamentals, the stock currently carries a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock&#39;s near-term price movements.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Another factor that confirms the company&#39;s fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock&#39;s near-term price performance.
So, the price trend in RCRRF may not reverse anytime soon.
<a href="https://www.zacks.com/stock/news/2306683/here-s-what-could-help-recruit-holdings-co-rcrrf-maintain-its-recent-price-strength?cid=CS-BENZ-FT-tale_of_the_tape|recent_price_strength_screen-2306683">To read this article on Zacks.com click here.</a>

RCRRF

Here's What Could Help Recruit Holdings Co. Maintain Its Recent Price Strength

On Tuesday, HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $17.05 billion</a>.
The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39903046/hca-healthcare-reports-second-quarter-2024-results" rel="noreferrer noopener">consensus of $5.36</a>.
&#8220;The company&#8217;s results for the second quarter were positive and reflected strong demand for our services,&#8221; said Sam Hazen, Chief Executive Officer of HCA Healthcare.
In the second quarter of 2024, same-facility admissions increased 5.8% year over year, while same-facility equivalent admissions increased 5.2%.
Same-facility emergency room visits increased by 5.5%. Same-facility inpatient surgeries increased 2.6%, and same-facility outpatient surgeries declined 2.1%.
Same facility revenue per equivalent admission increased by 4.4%
For the second quarter of 2024, adjusted EBITDA totaled $3.55 billion, compared to $3.06 billion a year ago.
Guidance:&nbsp;HCA Healthcare&nbsp;revised its fiscal year 2024 revenue guidance to $69.75 billion-$71.75 billion compared to <a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38463623/why-is-hca-healthcare-stock-trading-lower-on-friday" rel="noreferrer noopener">prior guidance of $67.75 billion-$70.25 billion</a> and the consensus of&nbsp;$69.79 billion.
The company forecasts 2024 EPS&nbsp;guidance&nbsp;of&nbsp;$21.60-22.80, up from the prior guidance of $19.70-$21.20&nbsp;and the consensus of&nbsp;$20.98.
The company expects 2024 adjusted EBITDA of $12.85 billion-$13.55 billion versus the prior guidance of $13.75 billion-$14.25 billion.
Reuters reported that some analysts anticipate U.S. hospitals will benefit from an aging population, while others believe a shift also drives the increased demand for ambulatory care centers that don&#8217;t require overnight stays.
Over the past year, demand for medical care has surged as Americans, particularly older adults, address non-urgent procedures delayed during the pandemic.
According to a Reuters report citing Mizuho analyst, the largest for-profit hospital operator in the U.S. raised its forecast, meeting the high expectations for the quarter.
The stock of peers Universal Health Services Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) and Community Health Systems Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) also trade higher.
Price Action:&nbsp;HCA Healthcare stock is up 4.81% at $341.33 at last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39903931/exclusive-adial-pharmaceuticals-moves-forward-to-second-cohort-in-pharmacokinetics-study-of-ad04-" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder</a>.</li>
</ul>
Photo via Company

Guidance

Health Care

Movers

Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook

Fiore Cannabis

July 6, 2022: Last week, California&rsquo;s onerous cultivation tax ($161/lb.) was officially eliminated. While far from solving all the issues for California operators, the tax change meaningfully reduces the break-even threshold for growers and particularly those with the biggest scale in capacity. In California, scale permits a meaningful wholesale price premium as retailers and distributors are typically willing to pay up to consolidate relationships as well as a lower total cost of production on greater volumes. The other driver of premium wholesale pricing is branded products. Brand power also tends to come with scale of operation given that brand success in the space is still largely predicated on distribution.

Some savings are likely to be passed on to distributors and retailers however without that we believe the total cost of production for outdoor growers is reduced by more than 40% with the elimination of the tax and the breakeven price for wholesalers is lowered from ~$375 to $214. The average price of outdoor grown flower in the state today is approximately $400/lbs and has been as low as $300 earlier this year.

Stocks for California operators have outperformed in recent months, in part on this expected law change. We expect stock outperformance to continue in the near term as market conditions for operators become more tenable which will translate to better earnings results than we have seen in the past and give investors greater confidence in long term opportunities. We also expect easier market conditions will accelerate consolidation in the state given the advantages of scale and the fact that larger operators now have more capital available to spend. Of public currently California-centric names, we expect 4front (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>), Glasshouse, Harborside (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HBORF#OTC">HBORF</a>), Lowell (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LOWLF#OTC">LOWLF</a>), Parent Company and Planet 13&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTC">PLNHF</a>) with each having already been acquisitive prior to the change.

The lower break-even threshold and seemingly more accommodating regulatory environment may also be the catalyst that finally brings the biggest MSOs into California. At some point, California as a market is too big to avoid and given the fact that California centric names continue to trade at meaningful valuation we expect entry to come through M&amp;A. All of the above mentioned public operators along with smaller public companies including: Body &amp; Mind (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>), Fiore (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FIORF#OTC">FIORF</a>), Unrivaled&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/UNRV#OTC">UNRV</a>) and Vibe are in play to be acquired in the near term and thus warrant further investor consideration. Within our coverage, we suspect that Ascend (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AAWH#OTC">AAWH</a>), AYR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>), Jushi (OTC:<a class="ticker" href="https://www.benzinga.com/stock/JUSHF#OTC">JUSHF</a>), Schwazze and TILT&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/TLLTF#OTC">TLLTF</a>) are likely to be the most interested in new California expansion.

Investment Highlights:

<ul>
	<li>California flower cultivation tax to be eliminated.</li>
	<li>Wholesale prices remain challenging at roughly 15% of East Coast states but the tax change meaningfully lowers the breakeven threshold for cultivators and permits some breathing room on operations.</li>
	<li>Expect further consolidation as scale proves even more beneficial and market conditions promote MSOs to meaningfully enter the market.</li>
	<li>Stocks of CA exposed companies are dispropionately cheap. Expect outperforming stock returns in the near term in correction of the discount as conditions seem now tenable.</li>
	<li>Outdoor growers dispropionately benefit.</li>
	<li>View biggest winners of tax change in our view are large CA cultivators including Glasshouse, Lowell Farms, Harborside, Parent Co and Planet 13.</li>
</ul>

Fiore Cannabis Ltd. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/FIOR#CSE">FIOR</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/FIORF#OTCQB">FIORF</a>) a company that intends to become a vertically integrated Canadian-American multi-state operator announced the closing of its Colorado merger with Unified Global&nbsp;on May 13, 2022.&nbsp;

&ldquo;This transaction enables the combined company to be a powerhouse platform for consolidating profitable operators with enhanced opportunities for cannabis entrepreneurs, investors, and stakeholders,&rdquo; stated Fiore in a press release.&nbsp;

The company seeks to improve its revenue-generating operations in Nevada and California and aggregate up to C$50 million of revenue opportunities after the transaction with Unified Global. Fiore intends to use the proceeds of the financing to fund the various acquisitions and corporate needs that support its corporate expansion strategy.&nbsp;

The Fiore and Unified Global combination is focused on closing up to 41 retail cannabis retail locations and cultivation facilities in Colorado, Oregon&nbsp;and Alberta to create the first Canadian-American multi-state operator (Can-Am MSO).&nbsp;

<h3>Management Commentary&nbsp;</h3>

&ldquo;I&rsquo;m very excited we have merged Unified Global with Fiore and will be leveraging the leadership from the talented Unified Global team that has over 100 combined years of cannabis experience when combined with Fiore&rsquo;s team. Unified Global has built out an amazing acquisition program and integration infrastructure, and is currently working with a US$200 million pipeline of M&amp;A opportunities,&rdquo; said Paul Lufkin, executive chairman and CEO of Unified Global, a subsidiary of Fiore.&nbsp;

&ldquo;We are actively growing our company as we look to consolidate profitable cannabis operators and generate enhanced options for cannabis entrepreneurs and investors,&rdquo; Lufkin added. &ldquo;This flexible financing option can play a vital role in providing us the dry powder to continue executing on our growth strategy and to drive shareholder value.&rdquo;

<h3>Financing From Institutional Fund&nbsp;&nbsp;</h3>

On May 16, Fiore signed a non-binding term sheet for financing up to C$30 million in Fiore common shares &ldquo;with an institutional fund proven to be supportive of the cannabis industry,&rdquo; according to a company press release. &ldquo;This financing was one of the relationships that were brought in by Unified as part of the merger.&rdquo;

The term sheet is subject to final due diligence and the parties entering into a definitive binding agreement, which is expected to be entered into within 30 days. Common shares will be issued at a price equal to the previous 15-day closing price of the common shares, minus a 10% discount.

Fiore will release further particulars concerning the financing once the parties have entered into a binding definitive agreement. &quot;There is no assurance that the financing will occur or that the parties will enter into a definitive agreement on the terms described or at all,&quot; per the release.&nbsp;

Image By Ilona Szentivanyi.&nbsp;

Fiore Cannabis: M&A In Colorado, Non-Binding Term Sheet For Financing Up To C$30M With Institutional Fund

A multi-state cannabis company Fiore Cannabis Ltd. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/FIOR#CSE">FIOR</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/FIORF#OTCQB">FIORF</a>) released its third-quarter 2021 financial results Monday&nbsp;with revenues of $1.11 million, up by 101% from $550,000 in the same quarter of 2020. Increased sales from the Apex Facility and solid retail performance at the California dispensary were the primary drivers.

<h3>Q3 Financial Highlights </h3>

<ul>
	<li>Gross profit was $297,000, compared with a gross profit of $158,000 in the third quarter of 2020</li>
	<li>General and administrative expenses were $1.19 million, which compares to $537,000 in the same period a year ago;</li>
	<li>Net profit amounted to $14,000, or nil per share, versus a net loss of $962,000, or $0.01 per share, in the corresponding quarter of 2020. Fiore Cannabis&rsquo; first recorded net profit in its history was primarily due to the gain on the sale of subsidiary companies.</li>
	<li>The company&#39;s deficit was $114,724 on September 30, 2021, essentially unchanged compared with $114,618 on June 30, 2021. Cash was $237,000 on September 30, 2021, slightly lower than the $406,000 on June 30, 2021.</li>
</ul>

&quot;The third quarter of this year has been a pivotal period for Fiore as we achieved a number of key milestones including recording our first quarterly net profit,&quot; Erik Anderson, president and CEO of Fiore Cannabis stated. &quot;We continued to build upon our strong first half of the year and focused on driving performance in our revenue-generating U.S. operations. During the quarter, we achieved strong sales activity at our Apex Cultivation and Production Facility in Las Vegas, Nevada and at our cannabis dispensary in Desert Hot Springs, California. Quarterly year-over-year revenues and gross profit were basically doubled at the same time that we kept our G&amp;A costs for year to date in check.&quot;

Anderson&nbsp;added that Fiore Cannabis&rsquo; plans for the rest of the year and 2022 are focused on expanding its operational presence in key U.S. markets.

&ldquo;Nevada and California are growth markets for cannabis products and are expected to see sales expand in the coming months as the tourist trade in both locations improves due to COVID-19 restrictions being reduced,&rdquo; Anderson noted. &ldquo;Additionally, we see positive signs for U.S. federal legalization of cannabis as the Republicans have joined the Democrats in proposing and drafting legislative options.&rdquo;

Price Action 

Fiore Cannabis&rsquo; shares traded 1.42% higher at $0.06 per share at the time of writing Monday morning. 

Photo: Courtesy of <a href="https://unsplash.com/@elsaolofsson?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Elsa Olofsson</a> on <a href="https://unsplash.com/s/photos/marijuana?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Fiore Cannabis

News

Latest news for Fiore Cannabis (OTC:FIORF) Stock

Wednesday, July 13, 2022

Tuesday, May 17, 2022

Monday, November 29, 2021